KenOliveLab

@KenOliveLab

Asc Prof. of Medicine, Columbia University, views own.
Pancreatic cancer, translational therapeutics, metabolism, systems, paracrine interactions. It all fits.

New York, NY, USA cancer.columbia.edu/profile/kennet… Joined August 2018

369 Following 3.7K Followers 2.5K Posts

Latest posts 5

Pinned post

KenOliveLab @KenOliveLab Apr 8, 2024

OK, this one is really meaningful for our whole team. Our preclinical paper on pan-RAS inhibition in pancreatic cancer is now online @Nature. Led by OliveLab student @ulawasko and Revolution Medicines colleagues JingJing Jiang and Mallika Singh. nature.com/articles/s4158…

www.nature.com Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer Nature - RMC-7977, a multi-selective RAS(ON) inhibitor, exhibits potent tumour-selective activity in multiple pre-clinical models of pancreatic ductal adenocarcinoma through a combination of...

KenOliveLab @KenOliveLab Nov 14, 2024

Suddenly seeing a huge number of fellow scientists show up on BlueSky. FYI I'm one of them. Come follow me: @kenolivelab.bsky.social

KenOliveLab @KenOliveLab Nov 1, 2024

New post on our website with updated information on the clinical development of RAS inhibitors for pancreatic cancer. I'll summarize on twitter sooner, but here's the full version: olivelab.org/ras-inhibitor-…

KenOliveLab @KenOliveLab Oct 25, 2024

Really excited for my postdoc @MC_Hasselluhn who received a 4th percentile score on her K99 application. Folks, she's on the job market!

KenOliveLab @KenOliveLab Sep 4, 2024

Hiring committees take note...

Alvaro Curiel-García, PhD @AlvaroCurielGa1 Sep 2, 2024

That feeling when you submit your first application for a tenure-track faculty! 🧑‍🔬 I am planing to create a "Translational systems oncology" laboratory focused on cell states, hypoxia and targeted therapies where I will use both wet and dry approaches. #faculty #academiclife
View quoted post on X